Chief Healthcare Executive July 28, 2024
A successful program will involve careful planning and regular communication and collaboration within the health system.
Emerging novel cell and gene therapies allow for the possibility of untethering patients from a lifetime of burdensome, costly chronic care with a single treatment.
The authorization of over thirty-five cell and gene therapies and the imminent approval of several additional advanced-stage gene therapies have left many hospitals and healthcare systems evaluating the cost-effectiveness and viability of these therapies prior to venturing into this burgeoning market segment.
While new gene therapies are shown to be very promising, the full clinical impact of these treatments is not yet known, driving questions on coverage, cost efficiency and delivery. Many health systems are also not set up...
Today's Sponsors
Today's Sponsor